A comprehensive assessment of cannabis use by patients with cancer has not previously been reported. In this study, we aimed to characterize patient perspectives about cannabis and its use.
What Cancer Patients Actually Know Regarding Medical Cannabis? A Cross-Sectional Survey With a Critical Analysis of the Current Attitudes
In Italy medical cannabis is a prescription drug since 1998. Even though it could not be considered a therapy as such, it is indicated as a symptomatic treatment also in cancer patients, to cure iatrogenic nausea/vomiting and chronic pain.
Interest in the medicinal use of cannabis and cannabinoids is mounting worldwide. Fueled by enthusiastic media coverage, patients perceive cannabinoids as a natural remedy for many symptoms.
The inauguration of Israel’s 35th government on May 17 was a particularly depressing event for many Israelis.
After all, they were watching one of the most bloated governments (34 ministers) in all of Israel’s history take office. But for the hundreds of thousands of cannabis users in Israel, it signified a happy change. For the first time in years, there is a real chance that cannabis will be fully legalized.
New regulations are in place at the federal and provincial levels in Canada regarding the way medical cannabis is to be controlled. We present them together with guidance for the safe use of medical cannabis and recent clinical trials on cannabis and pain.
Cannabis has the potential to modulate some of the most common and debilitating symptoms of cancer and its treatments, including nausea and vomiting, loss of appetite, and pain.
For years, cannabis stocks were virtually unstoppable. Following a more-than-tripling in worldwide sales between 2014 and 2018 to $10.9 billion, Wall Street and investors sent pot stock valuations into the stratosphere.
The use of medical marijuana in cancer care presents a dilemma for both patients and physicians. The scientific evidence is evolving, yet much of the known information is still insufficient to adequately inform patients as to risks and benefits. In addition, evidence-based dosing and administration information on medical marijuana is lacking.
Cannabis researchers in Canada say the plant-based drug may provide resistance to SARS-CoV-2. Their preliminary findings are part of broader research into the use of medicinal cannabis in treating cancer.
Delays in passing new laws governing the possession and use of cannabis, caused by the Covid-19 lockdown, have placed on hold the development of a different kind of green economy mentioned by President Cyril Rampahosa in his February State of the Nation address.